Harwood Feffer LLP Announces Investigation of PSS World Medical,
Inc.
NEW YORK, Oct. 25, 2012 /PRNewswire/ -- Harwood Feffer
LLP (www.hfesq.com) is investigating potential claims against the
board of directors of PSS World Medical, Inc. ("PSS World Medical"
or the "Company") (Nasdaq: PSSI) concerning the proposed
acquisition of the Company by McKesson Corporation ("McKesson") in
a cash and debt transaction valued at approximately $2.1 billion.
(Logo:
http://photos.prnewswire.com/prnh/20120215/MM54604LOGO)
On October 25, 2012, PSS World
Medical and McKesson announced that they have entered into a
definitive agreement providing for McKesson to acquire PSS World
Medical for $2.1 billion (including
the assumption of debt). Under the terms of the merger agreement,
PSS World Medical shareholders will receive $29.00 per share in cash.
The firm's investigation concerns whether PSS World Medical's
board of directors breached its fiduciary duties by failing to
adequately solicit competing bidders for the Company and obtaining
the best possible value for PSS World Medical's shareholders before
entering into an agreement with McKesson.
If you own PSS World Medical shares and wish to discuss your
rights and interests with regard to this matter, please
contact:
Robert I. Harwood, Esq.
Christopher J. Safrath
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400
(212) 935-7400
Email: csafrath@hfesq.com
Website: http://www.hfesq.com
Harwood Feffer has been
representing individual and institutional investors for many years,
serving as lead counsel in numerous cases in federal and state
courts. Please visit the Harwood Feffer LLP website
(http://www.hfesq.com) for more information about the firm.
Attorney Advertising© 2012 Harwood Feffer LLP. The law firm
responsible for this advertisement is Harwood Feffer LLP
(www.hfesq.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter.
SOURCE Harwood Feffer LLP